Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Neglected Tropical Diseases Drugs and Vaccine Market Growth (Status and Outlook) 2022-2028

  • LP 4805569
  • 100 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Neglected Tropical Diseases Drugs and Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global Neglected Tropical Diseases Drugs and Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Neglected Tropical Diseases Drugs and Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Neglected Tropical Diseases Drugs and Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Neglected Tropical Diseases Drugs and Vaccine market, reaching US$ million by the year 2028. As for the Europe Neglected Tropical Diseases Drugs and Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Neglected Tropical Diseases Drugs and Vaccine players cover Artecef BV, GlaxoSmithKline, AstraZeneca, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Neglected Tropical Diseases Drugs and Vaccine market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Malaria

Ebola

Dengue

Chagas

Leishmaniasis

Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Drugs

Vaccines

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Artecef BV

GlaxoSmithKline

AstraZeneca

Novartis

Sanofi-Aventis

Ranbaxy Labs

Lupin

Macleods Pharmaceuticals

Cipla

Romark Laboratories

Toyama Chemica

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size 2017-2028

2.1.2 Neglected Tropical Diseases Drugs and Vaccine Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Neglected Tropical Diseases Drugs and Vaccine Segment by Type

2.2.1 Malaria

2.2.2 Ebola

2.2.3 Dengue

2.2.4 Chagas

2.2.5 Leishmaniasis

2.2.6 Other

2.3 Neglected Tropical Diseases Drugs and Vaccine Market Size by Type

2.3.1 Neglected Tropical Diseases Drugs and Vaccine Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type (2017-2022)

2.4 Neglected Tropical Diseases Drugs and Vaccine Segment by Application

2.4.1 Drugs

2.4.2 Vaccines

2.5 Neglected Tropical Diseases Drugs and Vaccine Market Size by Application

2.5.1 Neglected Tropical Diseases Drugs and Vaccine Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application (2017-2022)

3 Neglected Tropical Diseases Drugs and Vaccine Market Size by Player

3.1 Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Players

3.1.1 Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Players (2020-2022)

3.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Players (2020-2022)

3.2 Global Neglected Tropical Diseases Drugs and Vaccine Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Neglected Tropical Diseases Drugs and Vaccine by Regions

4.1 Neglected Tropical Diseases Drugs and Vaccine Market Size by Regions (2017-2022)

4.2 Americas Neglected Tropical Diseases Drugs and Vaccine Market Size Growth (2017-2022)

4.3 APAC Neglected Tropical Diseases Drugs and Vaccine Market Size Growth (2017-2022)

4.4 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Growth (2017-2022)

4.5 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Growth (2017-2022)

5 Americas

5.1 Americas Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022)

5.2 Americas Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022)

5.3 Americas Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2017-2022)

6.2 APAC Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022)

6.3 APAC Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Neglected Tropical Diseases Drugs and Vaccine by Country (2017-2022)

7.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022)

7.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine by Region (2017-2022)

8.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022)

8.3 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Neglected Tropical Diseases Drugs and Vaccine Market Forecast

10.1 Global Neglected Tropical Diseases Drugs and Vaccine Forecast by Regions (2023-2028)

10.1.1 Global Neglected Tropical Diseases Drugs and Vaccine Forecast by Regions (2023-2028)

10.1.2 Americas Neglected Tropical Diseases Drugs and Vaccine Forecast

10.1.3 APAC Neglected Tropical Diseases Drugs and Vaccine Forecast

10.1.4 Europe Neglected Tropical Diseases Drugs and Vaccine Forecast

10.1.5 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Forecast

10.2 Americas Neglected Tropical Diseases Drugs and Vaccine Forecast by Country (2023-2028)

10.2.1 United States Neglected Tropical Diseases Drugs and Vaccine Market Forecast

10.2.2 Canada Neglected Tropical Diseases Drugs and Vaccine Market Forecast

10.2.3 Mexico Neglected Tropical Diseases Drugs and Vaccine Market Forecast

10.2.4 Brazil Neglected Tropical Diseases Drugs and Vaccine Market Forecast

10.3 APAC Neglected Tropical Diseases Drugs and Vaccine Forecast by Region (2023-2028)

10.3.1 China Neglected Tropical Diseases Drugs and Vaccine Market Forecast

10.3.2 Japan Neglected Tropical Diseases Drugs and Vaccine Market Forecast

10.3.3 Korea Neglected Tropical Diseases Drugs and Vaccine Market Forecast

10.3.4 Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Forecast

10.3.5 India Neglected Tropical Diseases Drugs and Vaccine Market Forecast

10.3.6 Australia Neglected Tropical Diseases Drugs and Vaccine Market Forecast

10.4 Europe Neglected Tropical Diseases Drugs and Vaccine Forecast by Country (2023-2028)

10.4.1 Germany Neglected Tropical Diseases Drugs and Vaccine Market Forecast

10.4.2 France Neglected Tropical Diseases Drugs and Vaccine Market Forecast

10.4.3 UK Neglected Tropical Diseases Drugs and Vaccine Market Forecast

10.4.4 Italy Neglected Tropical Diseases Drugs and Vaccine Market Forecast

10.4.5 Russia Neglected Tropical Diseases Drugs and Vaccine Market Forecast

10.5 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Forecast by Region (2023-2028)

10.5.1 Egypt Neglected Tropical Diseases Drugs and Vaccine Market Forecast

10.5.2 South Africa Neglected Tropical Diseases Drugs and Vaccine Market Forecast

10.5.3 Israel Neglected Tropical Diseases Drugs and Vaccine Market Forecast

10.5.4 Turkey Neglected Tropical Diseases Drugs and Vaccine Market Forecast

10.5.5 GCC Countries Neglected Tropical Diseases Drugs and Vaccine Market Forecast

10.6 Global Neglected Tropical Diseases Drugs and Vaccine Forecast by Type (2023-2028)

10.7 Global Neglected Tropical Diseases Drugs and Vaccine Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Artecef BV

11.1.1 Artecef BV Company Information

11.1.2 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Offered

11.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Artecef BV Main Business Overview

11.1.5 Artecef BV Latest Developments

11.2 GlaxoSmithKline

11.2.1 GlaxoSmithKline Company Information

11.2.2 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Offered

11.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 GlaxoSmithKline Main Business Overview

11.2.5 GlaxoSmithKline Latest Developments

11.3 AstraZeneca

11.3.1 AstraZeneca Company Information

11.3.2 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Offered

11.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 AstraZeneca Main Business Overview

11.3.5 AstraZeneca Latest Developments

11.4 Novartis

11.4.1 Novartis Company Information

11.4.2 Novartis Neglected Tropical Diseases Drugs and Vaccine Product Offered

11.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Novartis Main Business Overview

11.4.5 Novartis Latest Developments

11.5 Sanofi-Aventis

11.5.1 Sanofi-Aventis Company Information

11.5.2 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Offered

11.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Sanofi-Aventis Main Business Overview

11.5.5 Sanofi-Aventis Latest Developments

11.6 Ranbaxy Labs

11.6.1 Ranbaxy Labs Company Information

11.6.2 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Offered

11.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Ranbaxy Labs Main Business Overview

11.6.5 Ranbaxy Labs Latest Developments

11.7 Lupin

11.7.1 Lupin Company Information

11.7.2 Lupin Neglected Tropical Diseases Drugs and Vaccine Product Offered

11.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Lupin Main Business Overview

11.7.5 Lupin Latest Developments

11.8 Macleods Pharmaceuticals

11.8.1 Macleods Pharmaceuticals Company Information

11.8.2 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Offered

11.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Macleods Pharmaceuticals Main Business Overview

11.8.5 Macleods Pharmaceuticals Latest Developments

11.9 Cipla

11.9.1 Cipla Company Information

11.9.2 Cipla Neglected Tropical Diseases Drugs and Vaccine Product Offered

11.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Cipla Main Business Overview

11.9.5 Cipla Latest Developments

11.10 Romark Laboratories

11.10.1 Romark Laboratories Company Information

11.10.2 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Offered

11.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Romark Laboratories Main Business Overview

11.10.5 Romark Laboratories Latest Developments

11.11 Toyama Chemica

11.11.1 Toyama Chemica Company Information

11.11.2 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Offered

11.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Toyama Chemica Main Business Overview

11.11.5 Toyama Chemica Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Neglected Tropical Diseases Drugs and Vaccine Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Malaria

Table 3. Major Players of Ebola

Table 4. Major Players of Dengue

Table 5. Major Players of Chagas

Table 6. Major Players of Leishmaniasis

Table 7. Major Players of Other

Table 8. Neglected Tropical Diseases Drugs and Vaccine Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022) & ($ Millions)

Table 10. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type (2017-2022)

Table 11. Neglected Tropical Diseases Drugs and Vaccine Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 12. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022) & ($ Millions)

Table 13. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application (2017-2022)

Table 14. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Players (2020-2022) & ($ Millions)

Table 15. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Player (2020-2022)

Table 16. Neglected Tropical Diseases Drugs and Vaccine Key Players Head office and Products Offered

Table 17. Neglected Tropical Diseases Drugs and Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 18. New Products and Potential Entrants

Table 19. Mergers & Acquisitions, Expansion

Table 20. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Regions 2017-2022 & ($ Millions)

Table 21. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Regions (2017-2022)

Table 22. Americas Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022) & ($ Millions)

Table 23. Americas Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Country (2017-2022)

Table 24. Americas Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022) & ($ Millions)

Table 25. Americas Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type (2017-2022)

Table 26. Americas Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022) & ($ Millions)

Table 27. Americas Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application (2017-2022)

Table 28. APAC Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2017-2022) & ($ Millions)

Table 29. APAC Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Region (2017-2022)

Table 30. APAC Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022) & ($ Millions)

Table 31. APAC Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type (2017-2022)

Table 32. APAC Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022) & ($ Millions)

Table 33. APAC Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application (2017-2022)

Table 34. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022) & ($ Millions)

Table 35. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Country (2017-2022)

Table 36. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022) & ($ Millions)

Table 37. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type (2017-2022)

Table 38. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022) & ($ Millions)

Table 39. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application (2017-2022)

Table 40. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Region (2017-2022)

Table 42. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type (2017-2022)

Table 44. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022) & ($ Millions)

Table 45. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application (2017-2022)

Table 46. Key Market Drivers & Growth Opportunities of Neglected Tropical Diseases Drugs and Vaccine

Table 47. Key Market Challenges & Risks of Neglected Tropical Diseases Drugs and Vaccine

Table 48. Key Industry Trends of Neglected Tropical Diseases Drugs and Vaccine

Table 49. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 50. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share Forecast by Regions (2023-2028)

Table 51. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 52. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share Forecast by Type (2023-2028)

Table 53. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 54. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share Forecast by Application (2023-2028)

Table 55. Artecef BV Details, Company Type, Neglected Tropical Diseases Drugs and Vaccine Area Served and Its Competitors

Table 56. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Offered

Table 57. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 58. Artecef BV Main Business

Table 59. Artecef BV Latest Developments

Table 60. GlaxoSmithKline Details, Company Type, Neglected Tropical Diseases Drugs and Vaccine Area Served and Its Competitors

Table 61. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Offered

Table 62. GlaxoSmithKline Main Business

Table 63. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 64. GlaxoSmithKline Latest Developments

Table 65. AstraZeneca Details, Company Type, Neglected Tropical Diseases Drugs and Vaccine Area Served and Its Competitors

Table 66. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Offered

Table 67. AstraZeneca Main Business

Table 68. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 69. AstraZeneca Latest Developments

Table 70. Novartis Details, Company Type, Neglected Tropical Diseases Drugs and Vaccine Area Served and Its Competitors

Table 71. Novartis Neglected Tropical Diseases Drugs and Vaccine Product Offered

Table 72. Novartis Main Business

Table 73. Novartis Neglected Tropical Diseases Drugs and Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 74. Novartis Latest Developments

Table 75. Sanofi-Aventis Details, Company Type, Neglected Tropical Diseases Drugs and Vaccine Area Served and Its Competitors

Table 76. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Offered

Table 77. Sanofi-Aventis Main Business

Table 78. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 79. Sanofi-Aventis Latest Developments

Table 80. Ranbaxy Labs Details, Company Type, Neglected Tropical Diseases Drugs and Vaccine Area Served and Its Competitors

Table 81. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Offered

Table 82. Ranbaxy Labs Main Business

Table 83. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 84. Ranbaxy Labs Latest Developments

Table 85. Lupin Details, Company Type, Neglected Tropical Diseases Drugs and Vaccine Area Served and Its Competitors

Table 86. Lupin Neglected Tropical Diseases Drugs and Vaccine Product Offered

Table 87. Lupin Main Business

Table 88. Lupin Neglected Tropical Diseases Drugs and Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 89. Lupin Latest Developments

Table 90. Macleods Pharmaceuticals Details, Company Type, Neglected Tropical Diseases Drugs and Vaccine Area Served and Its Competitors

Table 91. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Offered

Table 92. Macleods Pharmaceuticals Main Business

Table 93. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 94. Macleods Pharmaceuticals Latest Developments

Table 95. Cipla Details, Company Type, Neglected Tropical Diseases Drugs and Vaccine Area Served and Its Competitors

Table 96. Cipla Neglected Tropical Diseases Drugs and Vaccine Product Offered

Table 97. Cipla Main Business

Table 98. Cipla Neglected Tropical Diseases Drugs and Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 99. Cipla Latest Developments

Table 100. Romark Laboratories Details, Company Type, Neglected Tropical Diseases Drugs and Vaccine Area Served and Its Competitors

Table 101. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Offered

Table 102. Romark Laboratories Main Business

Table 103. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Romark Laboratories Latest Developments

Table 105. Toyama Chemica Details, Company Type, Neglected Tropical Diseases Drugs and Vaccine Area Served and Its Competitors

Table 106. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Offered

Table 107. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 108. Toyama Chemica Main Business

Table 109. Toyama Chemica Latest Developments

List of Figures

Figure 1. Neglected Tropical Diseases Drugs and Vaccine Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type in 2021

Figure 7. Neglected Tropical Diseases Drugs and Vaccine in Drugs

Figure 8. Global Neglected Tropical Diseases Drugs and Vaccine Market: Drugs (2017-2022) & ($ Millions)

Figure 9. Neglected Tropical Diseases Drugs and Vaccine in Vaccines

Figure 10. Global Neglected Tropical Diseases Drugs and Vaccine Market: Vaccines (2017-2022) & ($ Millions)

Figure 11. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application in 2021

Figure 12. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Player in 2021

Figure 13. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Regions (2017-2022)

Figure 14. Americas Neglected Tropical Diseases Drugs and Vaccine Market Size 2017-2022 ($ Millions)

Figure 15. APAC Neglected Tropical Diseases Drugs and Vaccine Market Size 2017-2022 ($ Millions)

Figure 16. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size 2017-2022 ($ Millions)

Figure 18. Americas Neglected Tropical Diseases Drugs and Vaccine Value Market Share by Country in 2021

Figure 19. Americas Neglected Tropical Diseases Drugs and Vaccine Consumption Market Share by Type in 2021

Figure 20. Americas Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application in 2021

Figure 21. United States Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Region in 2021

Figure 26. APAC Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application in 2021

Figure 27. China Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 31. India Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Country in 2021

Figure 34. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type in 2021

Figure 35. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application in 2021

Figure 36. Germany Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 37. France Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Application in 2021

Figure 44. Egypt Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country Neglected Tropical Diseases Drugs and Vaccine Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 50. APAC Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 51. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 53. United States Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 54. Canada Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 55. Mexico Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 56. Brazil Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 57. China Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 58. Japan Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 59. Korea Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 61. India Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 62. Australia Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 63. Germany Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 64. France Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 65. UK Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 66. Italy Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 67. Russia Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 68. Spain Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 69. Egypt Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 70. South Africa Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 71. Israel Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 72. Turkey Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries Neglected Tropical Diseases Drugs and Vaccine Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390